Clinical Trial Patient Recruitment Services Market

Table of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of Clinical Trials
3.2.1 Clinical Trial Phases
3.3. Patient Recruitment in Clinical Trials
3.3.1. Patient Recruitment Process
3.3.2. Challenges Associated with Patient Recruitment
3.3.3. Strategies to Improve Patient Recruitment
3.3.4. Ethical Considerations

3.4. Outsourcing Patient Recruitment
3.4.1. Patient Recruitment-related Services

3.5. Patient Retention
3.5.1. Patient Retention-related Services

3.6. Concluding Remarks

4. PATIENT OUTREACH METHODS
4.1. Chapter Overview
4.2. Patient Outreach Methods
4.2.1. Traditional Patient Outreach Methods
4.2.1.1. Physician Referrals
4.2.1.2. Television
4.2.1.3. Radio
4.2.1.4. Print Media
4.2.1.5. Direct Mail Campaign
4.2.1.6. Cold Call / Call Centre
4.2.1.7. Advantages and Limitations of Traditional Media

4.2.2. Emerging Patient Outreach Methods
4.2.2.1. Social Media
4.2.2.1.1. Geo-Social Media
4.2.2.1.2. Social Networking Websites
4.2.2.1.3. Advantages and Limitations of Social Media
4.2.2.2. Mobile / Software Applications
4.2.2.3. Patient Networks
4.2.2.4. Patient Advocacy Groups
4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Registries
4.2.2.6. Search Engine Marketing / Artificial Intelligence-based Marketing
4.2.2.7. Over-the-top (OTT) Media Platforms
4.2.2.8. Indication Specific Events for Patients

4.2.3. Best Practices / Recommendations for Patient Outreach

5. MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Patient Recruitment Companies: Overall Market Landscape
5.2.1. Analysis by Year of Establishment 
5.2.2. Analysis by Company Size
5.2.3. Analysis by Location of Headquarters  
5.2.4. Analysis by Company Size and Location of Headquarters
5.2.5. Analysis by Patient Recruitment Services Offered
5.2.6. Analysis by Patient Outreach Methods
5.2.7. Analysis by Patient Recruitment Associated Service(s) Offered
5.2.8. Analysis by Patient Retention Method(s) Used
5.2.9. Analysis by Geographical Reach
5.2.10. Analysis by Therapeutic Expertise
5.2.11. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status

6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.3. Methodology
6.4. Patient Recruitment Companies: Company Competitiveness Analysis
6.4.1. Competitiveness Analysis: Small Companies
6.4.2. Competitiveness Analysis: Mid-Sized Companies
6.4.3. Competitiveness Analysis: Large and Very Large Companies

7. COMPANY PROFILES: CLINICAL TRIAL RECRUITMENT COMPANIES IN NORTH AMERICA
7.1. Chapter Overview
7.2. BBK Worldwide (A Publicis Health Company)
7.2.1. Company Overview
7.2.2. Patient Recruitment and Retention Services Portfolio
7.2.3. Recent Developments and Future Outlook

7.3. Continuum Clinical
7.3.1. Company Overview
7.3.2. Patient Recruitment and Retention Services Portfolio
7.3.3. Recent Developments and Future Outlook

7.4. IQVIA
7.4.1. Company Overview
7.4.2. Patient Recruitment and Retention Services Portfolio
7.4.3. Recent Developments and Future Outlook

7.5. United BioSource (UBC)
7.5.1. Company Overview
7.5.2. Patient Recruitment and Retention Services Portfolio
7.5.3. Recent Developments and Future Outlook

7.6. WCG ThreeWire
7.6.1. Company Overview
7.6.2. Patient Recruitment and Retention Services Portfolio
7.6.3. Recent Developments and Future Outlook

8. COMPANY PROFILES: CLINICAL TRIAL RECRUITMENT COMPANIES IN EUROPE
8.1. Chapter Overview
8.2. Clariness
8.2.1. Company Overview
8.2.2. Patient Recruitment and Retention Services Portfolio
8.2.3. Recent Developments and Future Outlook

8.3. Ignite Data
8.3.1. Company Overview
8.3.2. Capsule Communications: Patient Recruitment and Retention Services Portfolio
8.3.3. Recent Developments and Future Outlook

8.4. Innovative Trials
8.4.1. Company Overview
8.4.2. Patient Recruitment and Retention Services Portfolio
8.4.3. Recent Developments and Future Outlook

8.5. One Research
8.5.1. Company Overview
8.5.2. Patient Recruitment and Retention Services Portfolio
8.5.3. Recent Developments and Future Outlook

8.6. Orphan Reach
8.6.1. Company Overview
8.6.2. Patient Recruitment and Retention Services Portfolio
8.6.3. Recent Developments and Future Outlook

9. COMPANY PROFILES: CLINICAL TRIAL PATIENT RECRUITMENT COMPANIES IN ASIA-PACIFIC AND REST OF THE WORLD
9.1. Chapter Overview
9.2. 3H Medi Solution
9.2.1. Company Overview
9.2.2. Patient Recruitment and Retention Services Portfolio
9.2.3. Recent Developments and Future Outlook

9.3. Buzzreach
9.3.1. Company Overview
9.3.2. Patient Recruitment and Retention Services Portfolio
9.3.3. Recent Developments and Future Outlook

9.4. Current Medical Information Center (CMIC)
9.4.1. Company Overview
9.4.2. Patient Recruitment and Retention Services Portfolio
9.4.3. Recent Developments and Future Outlook

9.5. nRollmed
9.5.1. Company Overview
9.5.2. Patient Recruitment and Retention Services Portfolio
9.5.3. Recent Developments and Future Outlook

9.6. Trialfacts
9.6.1. Company Overview
9.6.2. Patient Recruitment and Retention Services Portfolio
9.6.3. Recent Developments and Future Outlook

10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Patient Recruitment Services: List of Partnerships and Collaborations
10.3.1. Analysis by Year of Partnership
10.3.2. Analysis by Type of Partnership
10.3.3. Analysis by Year and Type of Partnership
10.3.4. Analysis by Focus Area
10.3.5. Analysis by Year of Partnership and Focus Area
10.3.6. Analysis by Therapeutic Area
10.3.7. Analysis by Type of Partner
10.3.8. Most Active Players: Analysis by Number of Partnerships
10.3.9. Analysis by Geography
10.3.9.1. Intracontinental and Intercontinental Deals
10.3.9.2. International and Local Deals

11. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION
11.1. Chapter Overview
11.1.1. Campaigning on Social Media to Accelerate Patient Recruitment in Clinical Trials
11.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
11.1.3. Use of EHR Data to Improve Patient Recruitment Rates
11.1.4. Use of Other Real-World Data Sources to Overcome Patient Enrolment-related Challenges
11.1.5. Use of Artificial Intelligence to Improve Patient Selection
11.1.6. Increase in Adoption of the Virtual Trial Model During the COVID-19 Pandemic
11.1.7. Growing Focus on Conducting Clinical Research in Emerging Markets

12. FUTURE GROWTH OPPORTUNITIES IN PATIENT RECRUITMENT
12.1. Chapter Overview
12.2. Continuous Rise in the Number of Global Clinical Trials
12.3. Rise in Demand for Orphan Drugs and Personalized Medicine
12.4. Increase in Offshoring Clinical Development Activity to Emerging Regions
12.5. Availability of Service Providers Offering One-Stop-Solutions
12.6. Stringent Regulations and Complex Study Protocols Prompting More Outsourcing
12.7. Impact of the COVID-19 Pandemic on Clinical Research Activity
12.8. Technological Advances in Clinical Trial Conduct

13. CASE STUDY: REGULATORY LANDSCAPE OF PATIENT RECRUITMENT
13.1. Chapter Overview
13.2. Regulatory Framework of Patient Recruitment
13.3. Regulations Involved in Patient Recruitment
13.3.1. ICH-GCP Guidelines
13.3.2. Declaration of Helsinki
13.3.3. General Data Privacy Regulation (GDPR)
13.3.4. Health Insurance Portability and Accountability Act (HIPAA)

14. PATIENT RECRUITMENT IN TRIALS FOCUSED ON PERSONALIZED MEDICINES AND RARE DISEASES
14.1. Chapter Overview
14.2. Clinical Trials Focused on Personalized Medicines and Rare Diseases
14.2.1. Key Challenges
14.2.2. Specialized Patient Outreach Methods
14.2.3. Key Players

15. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Clinical Trial Analysis
15.3.1. Analysis by Trial Registration Year and Enrolled Patient Population
15.3.2. Analysis by Trial Phase

15.4. Global Demand for Clinical Trial Participants
15.4.1. Analysis by Enrolled Patient Population
15.4.2. Analysis by Trial Phase
15.4.3. Analysis by Therapeutic Area
15.4.4. Analysis by Enrolled Patient Population and Geography

16. MARKET SIZING AND OPPORTUNITY ANALYSIS
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Global Clinical Trial Patient Recruitment Services: Market Size, 2022-2035
16.4. Clinical Trial Patient Recruitment Services Market: Analysis by Patient Recruitment Steps, 2022-2035
16.5. Clinical Trial Patient Recruitment Services Market: Analysis by Trial Phase, 2022-2035
16.6. Clinical Trial Patient Recruitment Services Market: Analysis by Therapeutic Area, 2022-2035

16.7. Clinical Trial Patient Recruitment Services Market: Analysis by Geography, 2022-2035
16.7.1. Clinical Trial Patient Recruitment Services: Market Attractiveness Analysis by Country, 2022-2035
16.7.2. Clinical Trial Patient Recruitment Services Market in North America, 2022-2035
16.7.2.1. Clinical Trial Patient Recruitment Services Market in the US: Analysis by Trial Phase, 2022-2035
16.7.2.2. Clinical Trial Patient Recruitment Services Market in the US: Analysis by Therapeutic Area, 2022-2035
16.7.2.3. Clinical Trial Patient Recruitment Services Market in Canada: Analysis by Trial Phase, 2022-2035
16.7.2.4. Clinical Trial Patient Recruitment Services Market in Canada: Analysis by Therapeutic Area, 2022-2035

16.7.3. Clinical Trial Patient Recruitment Services Market in Europe, 2022-2035
16.7.3.1. Clinical Trial Patient Recruitment Services Market in Germany: Analysis by Trial Phase, 2022-2035
16.7.3.2. Clinical Trial Patient Recruitment Services Market in Germany: Analysis by Therapeutic Area, 2022-2035
16.7.3.3. Clinical Trial Patient Recruitment Services Market in France: Analysis by Trial Phase, 2022-2035
16.7.3.4. Clinical Trial Patient Recruitment Services Market in France: Analysis by Therapeutic Area, 2022-2035
16.7.3.5. Clinical Trial Patient Recruitment Services Market in the UK: Analysis by Trial Phase, 2022-2035
16.7.3.6. Clinical Trial Patient Recruitment Services Market in the UK: Analysis by Therapeutic Area, 2022-2035
16.7.3.7. Clinical Trial Patient Recruitment Services Market in Italy: Analysis by Trial Phase, 2022-2035
16.7.3.8. Clinical Trial Patient Recruitment Services Market in Italy: Analysis by Therapeutic Area, 2022-2035
16.7.3.9. Clinical Trial Patient Recruitment Services Market in Spain: Analysis by Trial Phase, 2022-2035
16.7.3.10. Clinical Trial Patient Recruitment Services Market in Spain: Analysis by Therapeutic Area, 2022-2035
16.7.3.11. Clinical Trial Patient Recruitment Services Market in Rest of Europe: Analysis by Trial Phase, 2022-2035
16.7.3.12. Clinical Trial Patient Recruitment Services Market in Rest of Europe: Analysis by Therapeutic Area, 2022-2035

16.7.4. Clinical Trial Patient Recruitment Services Market in Asia-Pacific, 2022-2035
16.7.4.1. Clinical Trial Patient Recruitment Services Market in Japan: Analysis by Trial Phase, 2022-2035
16.7.4.2. Clinical Trial Patient Recruitment Services Market in Japan: Analysis by Therapeutic Area, 2022-2035
16.7.4.3. Clinical Trial Patient Recruitment Services Market in South Korea: Analysis by Trial Phase, 2022-2035
16.7.4.4. Clinical Trial Patient Recruitment Services Market in South Korea: Analysis by Therapeutic Area, 2022-2035
16.7.4.5. Clinical Trial Patient Recruitment Services Market in Australia: Analysis by Trial Phase, 2022-2035
16.7.4.6. Clinical Trial Patient Recruitment Services Market in Australia: Analysis by Therapeutic Area, 2022-2035
16.7.4.7. Clinical Trial Patient Recruitment Services Market in China: Analysis by Trial Phase, 2022-2035
16.7.4.8. Clinical Trial Patient Recruitment Services Market in China: Analysis by Therapeutic Area, 2022-2035
16.7.4.9. Clinical Trial Patient Recruitment Services Market in India: Analysis by Trial Phase, 2022-2035
16.7.4.10. Clinical Trial Patient Recruitment Services Market in India: Analysis by Therapeutic Area, 2022-2035

16.7.5 Clinical Trial Patient Recruitment Services Market in Latin America, 2022-2035
16.7.5.1. Clinical Trial Patient Recruitment Services Market in Latin America: Analysis by Trial Phase, 2022-2035
16.7.5.2. Clinical Trial Patient Recruitment Services Market in Latin America: Analysis by Therapeutic Area, 2022-2035
 
16.7.6. Clinical Trial Patient Recruitment Services Market in Middle East and North Africa, 2022-2035
16.7.6.1. Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Analysis by Trial Phase, 2022-2035
16.7.6.2. Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Analysis by Therapeutic Area, 2022-2035

16.7.7. Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035
16.7.7.1. Clinical Trial Patient Recruitment Services Market in Rest of the World: Analysis by Trial Phase, 2022-2035
16.7.7.2. Clinical Trial Patient Recruitment Services Market in Rest of the World: Analysis by Therapeutic Area, 2022-2035

17. IMPACT OF THE COVID-19 PANDEMIC ON PATIENT RECRUITMENT SERVICES MARKET
17.1. Chapter Overview
17.2. Impact of COVID-19 Pandemic on Clinical Trials
17.2.1. Impact on Opportunity Related to Patient Recruitment Services
17.2.2. Initiatives Undertaken by Key Patient Recruitment Companies
17.2.2.1. Trialspark
17.2.2.2. BBK Worldwide
17.2.2.3. Clariness
17.2.2.4. Clinical Site Services (CSSi)
17.2.2.5. IQVIA
17.3. Key Strategies Adopted to Mitigate the Challenges Associated with Patient Recruitment and Retention

18. CONCLUDING REMARKS

19. EXECUTIVE INSIGHTS
19.1. Chapter Overview
19.2. TrialWire
19.2.1. Company Snapshot
19.2.2. Interview Transcript: Director

19.3. Innovative Trials
19.3.1. Company Snapshot
19.3.2. Interview Transcript: Chief Executive Officer, and Marketing and Communications Manager

19.4. Link2Trials
19.4.1. Company Snapshot
19.4.2. Interview Transcript: Managing Director

19.5. Clariness
19.5.1. Company Snapshot
19.5.2. Interview Transcript: Chief Commercial Officer

19.6. Continuum Clinical
19.6.1. Company Snapshot
19.6.2. Interview Transcript: Chief Commercial Officer

19.7. nRollmed
19.7.1. Company Snapshot
19.7.2. Interview Transcript: Chief Operation Officer and Business Development Officer

19.8. Seeker Health
19.8.1. Company Snapshot
19.8.2. Interview Transcript: Ex Managing Director

19.9. EVERSANA
19.9.1. Company Snapshot
19.9.2. Interview Transcript: Inside Sales Specialist

20. APPENDIX 1: TABULATED DATA

21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS 

List of Figures

Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnership and Collaborations
Figure 2.3 Executive Summary: Analysis of Demand for Clinical Trial Participants
Figure 2.4 Executive Summary: Market Sizing and Opportunity Analysis
Figure 3.1 Factors Contributing to Clinical Trial Cost
Figure 3.2 Patient Recruitment Process
Figure 3.3 Factors Influencing Participation in Clinical Trials
Figure 3.4 Reasons for Patient Dropouts from Clinical Studies
Figure 4.1 Patient Outreach: Advantages and Limitations of Traditional Methods
Figure 4.2 Patient Outreach: Advantages and Limitations of Social Media
Figure 5.1 Patient Recruitment Companies: Distribution by Year of Establishment
Figure 5.2 Patient Recruitment Companies: Distribution by Company Size
Figure 5.3 Patient Recruitment Companies: Distribution by Location of Headquarters (Region-wise)
Figure 5.4 Patient Recruitment Companies: Distribution by Location of Headquarters (Country-wise)
Figure 5.5 Patient Recruitment Companies: Distribution by Company Size and Location of Headquarters
Figure 5.6 Patient Recruitment Companies: Distribution by Patient Recruitment and Retention Services Offered
Figure 5.7 Patient Recruitment Companies: Distribution by Type of Patient Outreach Methods
Figure 5.8 Patient Recruitment Companies: Distribution by Number of Patient Outreach Methods Offered
Figure 5.9 Patient Recruitment Companies: Distribution by Patient Recruitment Associated Service(s) Offered
Figure 5.10 Patient Recruitment Companies: Distribution by Number of Patient Recruitment Associated Service(s) Offered
Figure 5.11 Patient Recruitment Companies: Distribution by Patient Retention Method(s) Used
Figure 5.12 Patient Recruitment Companies: Distribution by Number of Patient Retention Method(s) Used
Figure 5.13 Patient Recruitment Companies: Distribution by Geographical Reach
Figure 5.14 Patient Recruitment Companies: Distribution by Therapeutic Expertise
Figure 6.1 Company Competitiveness Analysis: Small Players
Figure 6.2 Company Competitiveness Analysis: Mid-sized Players
Figure 6.3 Company Competitiveness Analysis: Large and Very Large Players
Figure 10.1 Partnerships and Collaborations: Cumulative Year-wise Distribution, 2013-2022
Figure 10.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 10.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2013-2022
Figure 10.4 Partnerships and Collaborations: Distribution by Focus Area
Figure 10.5 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
Figure 10.6 Partnerships and Collaborations: Distribution by Therapeutic Area
Figure 10.7 Partnerships and Collaborations: Distribution by Type of Partner
Figure 10.8 Most Active Players: Distribution by Number of Partnerships
Figure 10.9 Partnerships and Collaborations: Intercontinental and Intracontinental Deals
Figure 10.10 Partnerships and Collaborations: International and Local Deals
Figure 11.1 Patient Recruitment Services Market: Recent Trends
Figure 12.1 Patient Recruitment Services Market: Future Growth Opportunities
Figure 12.2 Global Clinical Trials Registered, 2000-2022
Figure 13.1 Patient Recruitment: Regulatory Pathway
Figure 13.2 Patient Recruitment: Regulatory Guidelines
Figure 14.1 Key Challenges in Patient Enrolment in Trials Focused on Personalized Medicines
Figure 14.2 Key Challenges in Patient Enrolment in Trials Focused on Rare Diseases
Figure 14.3 Specialized Patient Outreach Methods
Figure 15.1 Clinical Trial Analysis: Distribution by Trial Registration Year and Enrolled Patient Population
Figure 15.2 Clinical Trial Analysis: Distribution by Trial Phase
Figure 15.3 Global Demand for Clinical Trial Participants: Distribution by Enrolled Patient Population
Figure 15.4 Global Demand for Clinical Trial Participants: Distribution by Trial Phase
Figure 15.5 Global Demand for Clinical Trial Participants: Distribution by Therapeutic Area
Figure 15.6 Global Demand for Clinical Trial Participants: Distribution by Geography
Figure 16.1 Global Clinical Trial Patient Recruitment Services Market, 2022-2035 (USD Billion)
Figure 16.2 Clinical Trial Patient Recruitment Services Market: Distribution by Patient Recruitment Steps, 2022-2035 (USD Billion)
Figure 16.3 Clinical Trial Patient Recruitment Services Market: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.4 Clinical Trial Patient Recruitment Services Market: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.5 Clinical Trial Patient Recruitment Services Market: Distribution by Geography, 2022-2035 (USD Billion)
Figure 16.6 Clinical Trial Patient Recruitment Services Market, 2022 and 2035: Market Attractiveness Distribution by Country
Figure 16.7 Clinical Trial Patient Recruitment Services Market in North America, 2022-2035 (USD Billion)
Figure 16.8 Clinical Trial Patient Recruitment Services Market in the US: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.9 Clinical Trial Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.10 Clinical Trial Patient Recruitment Services Market in Canada: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.11 Clinical Trial Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.12 Clinical Trial Patient Recruitment Services Market in Europe, 2022-2035 (USD Billion)
Figure 16.13 Clinical Trial Patient Recruitment Services Market in Germany: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.14 Clinical Trial Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.15 Clinical Trial Patient Recruitment Services Market in France: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.16 Clinical Trial Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.17 Clinical Trial Patient Recruitment Services Market in the UK: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.18 Clinical Trial Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.19 Clinical Trial Patient Recruitment Services Market in Italy: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.20 Clinical Trial Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.21 Clinical Trial Patient Recruitment Services Market in Spain: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.22 Clinical Trial Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.23 Clinical Trial Patient Recruitment Services Market in Rest of Europe: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.24 Clinical Trial Patient Recruitment Services Market in Rest of Europe: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.25 Clinical Trial Patient Recruitment Services Market in Asia Pacific, 2022-2035 (USD Billion)
Figure 16.26 Clinical Trial Patient Recruitment Services Market in Japan: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.27 Clinical Trial Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.28 Clinical Trial Patient Recruitment Services Market in South Korea: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.29 Clinical Trial Patient Recruitment Services Market in South Korea, 2022-2035: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.30 Clinical Trial Patient Recruitment Services Market in Australia: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.31 Clinical Trial Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area (USD Billion)
Figure 16.32 Clinical Trial Patient Recruitment Services Market in China: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.33 Clinical Trial Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.34 Clinical Trial Patient Recruitment Services Market in India: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.35 Clinical Trial Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.36 Clinical Trial Patient Recruitment Services Market in Latin America, 2022-2035 (USD Billion)
Figure 16.37 Clinical Trial Patient Recruitment Services Market in Latin America: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.38 Clinical Trial Patient Recruitment Services Market in Latin America: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.39 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa, 2022-2035 (USD Billion)
Figure 16.40 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.41 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 16.42 Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035 (USD Billion)
Figure 16.43 Clinical Trial Patient Recruitment Services Market in Rest of the World: Distribution by Trial Phase, 2022-2035 (USD Billion)
Figure 16.44 Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Figure 18.1 Concluding Remarks: Overall Market Landscape
Figure 18.2 Concluding Remarks: Company Competitiveness Analysis
Figure 18.3 Concluding Remarks: Partnership and Collaborations
Figure 18.4 Concluding Remarks: Analysis of Demand for Clinical Trial Participants
Figure 18.5 Concluding Remarks: Market Sizing and Opportunity Analysis

List of Tables

Table 3.1 Key Characteristics of Clinical Trial Phases
Table 4.1 Traditional and Emerging Patient Outreach Methods
Table 5.1 List of Patient Recruitment and Retention Service Providers
Table 5.2 Clinical Trial Recruitment Companies: Information on Patient Outreach Methods
Table 5.3 Clinical Trial Recruitment Companies: Information on Type of Patient Recruitment Service(s) Offered
Table 5.4 Clinical Trial Recruitment Companies: Information on Patient Retention Method(s) Used and Geographical Reach
Table 5.5 Clinical Trial Recruitment Companies: Information on Therapeutic Expertise
Table 5.6 Clinical Trial Recruitment Companies: Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
Table 7.1 Leading Clinical Trial Recruitment Companies in North America
Table 7.2 BBK Worldwide: Company Overview
Table 7.3 BBK Worldwide: Patient Recruitment and Retention Services Portfolio
Table 7.4 BBK Worldwide: Recent Developments and Future Outlook
Table 7.5 Continuum Clinical: Company Overview
Table 7.6 Continuum Clinical: Patient Recruitment and Retention Services Portfolio
Table 7.7 Continuum Clinical: Recent Developments and Future Outlook
Table 7.8 IQVIA: Company Overview
Table 7.9 IQVIA: Patient Recruitment and Retention Services Portfolio
Table 7.10 IQVIA: Recent Developments and Future Outlook
Table 7.11 United BioSource: Company Overview
Table 7.12 United BioSource: Patient Recruitment and Retention Services Portfolio
Table 7.13 United BioSource: Recent Developments and Future Outlook
Table 7.14 WCG ThreeWire: Company Overview
Table 7.15 WCG ThreeWire: Patient Recruitment and Retention Services Portfolio
Table 7.16 WCG ThreeWire: Recent Developments and Future Outlook
Table 8.1 Leading Clinical Trial Recruitment Companies in Europe
Table 8.2 Clariness: Company Overview
Table 8.3 Clariness: Patient Recruitment and Retention Services Portfolio
Table 8.4 Clariness: Recent Developments and Future Outlook
Table 8.5 Ignite Data: Company Overview
Table 8.6 Ignite Data: Patient Recruitment and Retention Services Portfolio
Table 8.7 Ignite Data: Recent Developments and Future Outlook
Table 8.8 Innovative Trials: Company Overview
Table 8.9 Innovative Trials: Patient Recruitment and Retention Services Portfolio
Table 8.10 Innovative Trials: Recent Developments and Future Outlook
Table 8.11 One Research: Company Overview
Table 8.12 One Research: Patient Recruitment and Retention Services Portfolio
Table 8.13 One Research: Recent Developments and Future Outlook
Table 8.14 Orphan Reach: Company Overview
Table 8.15 Orphan Reach: Patient Recruitment and Retention Services Portfolio
Table 8.16 Orphan Reach: Recent Developments and Future Outlook
Table 9.1 Leading Clinical Trial Recruitment Companies in Asia Pacific and Rest of the World
Table 9.2 3H Medi Solution: Company Overview
Table 9.3 3H Medi Solution: Patient Recruitment and Retention Services Portfolio
Table 9.4 3H Medi Solution: Recent Developments and Future Outlook
Table 9.5 Buzzreach: Company Overview
Table 9.6 Buzzreach: Patient Recruitment and Retention Services Portfolio
Table 9.7 Buzzreach: Recent Developments and Future Outlook
Table 9.8 Current Medical Information Center: Company Overview
Table 9.9 Current Medical Information Center: Patient Recruitment and Retention Services Portfolio
Table 9.10 Current Medical Information Center: Recent Developments and Future Outlook
Table 9.11 nRollmed: Company Overview
Table 9.12 nRollmed: Patient Recruitment and Retention Services PortfolioF
Table 9.13 Trialfacts: Company Overview
Table 9.14 Trialfacts: Patient Recruitment and Retention Services Portfolio
Table 9.15 Trialfacts: Recent Developments and Future Outlook
Table 10.1 Patient Recruitment Services: List of Partnerships and Collaborations, 2013-2022
Table 14.1 Patient Recruitment Companies: List of Trials Focused on Personalized Medicines and Rare Diseases
Table 19.1 TrialWire: Company Snapshot
Table 19.2 Innovative Trials: Company Snapshot
Table 19.3 Link2Trials: Company Snapshot
Table 19.4 Clariness: Company Snapshot
Table 19.5 Continuum Clinical: Company Snapshot
Table 19.6 nRollmed: Company Snapshot
Table 19.7 Seeker Health: Company Snapshot
Table 19.8 EVERSANA: Company Snapshot
Table 20.1 Factors Contributing to Clinical Trial Cost
Table 20.2 Clinical Trial Recruitment Companies: Distribution by Year of Establishment
Table 20.3 Clinical Trial Recruitment Companies: Distribution by Company Size
Table 20.4 Clinical Trial Recruitment Companies: Distribution by Location of Headquarters (Region-wise)
Table 20.5 Clinical Trial Recruitment Companies: Distribution by Location of Headquarters (Country-wise)
Table 20.6 Clinical Trial Recruitment Companies: Distribution by Company Size and Location of Headquarters
Table 20.7 Clinical Trial Recruitment Companies: Distribution by Patient Recruitment and Retention Services Offered
Table 20.8 Clinical Trial Recruitment Companies: Distribution by Type of Patient Outreach Methods
Table 20.9 Clinical Trial Recruitment Companies: Distribution by Number of Patient Outreach Methods Offered
Table 20.10 Clinical Trial Recruitment Companies: Distribution by Patient Recruitment Associated Service(s) Offered
Table 20.11 Clinical Trial Recruitment Companies: Distribution by Number of Patient Recruitment Associated Service(s) Offered
Table 20.12 Clinical Trial Recruitment Companies: Distribution by Patient Retention Method(s) Used
Table 20.13 Clinical Trial Recruitment Companies: Distribution by Number of Patient Retention Method(s) Used
Table 20.14 Clinical Trial Recruitment Companies: Distribution by Geographical Reach
Table 20.15 Clinical Trial Recruitment Companies: Distribution by Therapeutic Expertise
Table 20.16 Partnerships and Collaborations: Cumulative Year-wise Distribution, 2013-2022
Table 20.17 Partnerships and Collaborations: Distribution by Type of Partnership
Table 20.18 Partnerships and Collaborations: Distribution by Year and Type of Partnership, 2013-2022
Table 20.19 Partnerships and Collaborations: Distribution by Focus Area
Table 20.20 Partnerships and Collaborations: Distribution by Year of Partnership and Focus Area
Table 20.21 Partnerships and Collaborations: Distribution by Therapeutic Area
Table 20.22 Partnerships and Collaborations: Distribution by Type of Partner
Table 20.23 Most Active Players: Distribution by Number of Partnerships
Table 20.24 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 20.25 Partnerships and Collaborations: International and Local Distribution
Table 20.26 Global Clinical Trials Registered, 2000-2022
Table 20.27 Clinical Trial Analysis: Distribution by Trial Registration Year and Enrolled Patient Population
Table 20.28 Clinical Trial Analysis: Distribution by Trial Phase
Table 20.29 Global Demand for Clinical Trial Participants: Distribution by Enrolled Patient Population
Table 20.30 Global Demand for Clinical Trial Participants: Distribution by Trial Phase
Table 20.31 Global Demand for Clinical Trial Participants: Distribution by Therapeutic Area
Table 20.32 Global Demand for Clinical Trial Participants: Distribution by Geography
Table 20.33 Global Clinical Trial Patient Recruitment Services Market, 2022-2035 (USD Billion)
Table 20.34 Clinical Trial Patient Recruitment Services Market: Distribution by Patient Recruitment Steps, 2022-2035 (USD Billion)
Table 20.35 Clinical Trial Patient Recruitment Services Market: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.36 Clinical Trial Patient Recruitment Services Market: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.37 Clinical Trial Patient Recruitment Services Market: Distribution by Geography, 2022-2035 (USD Billion)
Table 20.38 Clinical Trial Patient Recruitment Services Market, 2022 and 2035: Market Attractiveness Distribution by Country
Table 20.39 Clinical Trial Patient Recruitment Services Market in North America, 2022-2035 (USD Billion)
Table 20.40 Clinical Trial Patient Recruitment Services Market in the US: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.41 Clinical Trial Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.42 Clinical Trial Patient Recruitment Services Market in Canada: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.43 Clinical Trial Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.44 Clinical Trial Patient Recruitment Services Market in Europe, 2022-2035 (USD Billion)
Table 20.45 Clinical Trial Patient Recruitment Services Market in Germany: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.46 Clinical Trial Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.47 Clinical Trial Patient Recruitment Services Market in France: Distribution by Trial Phase,2022-2035 (USD Billion)
Table 20.48 Clinical Trial Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.49 Clinical Trial Patient Recruitment Services Market in the UK: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.50 Clinical Trial Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.51 Clinical Trial Patient Recruitment Services Market in Italy: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.52 Clinical Trial Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.53 Clinical Trial Patient Recruitment Services Market in Spain: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.54 Clinical Trial Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.55 Clinical Trial Patient Recruitment Services Market in Rest of Europe: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.56 Clinical Trial Patient Recruitment Services Market in Rest of Europe: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.57 Clinical Trial Patient Recruitment Services Market in Asia Pacific, 2022-2035 (USD Billion)
Table 20.58 Clinical Trial Patient Recruitment Services Market in Japan: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.59 Clinical Trial Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.60 Clinical Trial Patient Recruitment Services Market in South Korea: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.61 Clinical Trial Patient Recruitment Services Market in South Korea, 2022-2035: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.62 Clinical Trial Patient Recruitment Services Market in Australia: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.63 Clinical Trial Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area (USD Billion)
Table 20.64 Clinical Trial Patient Recruitment Services Market in China: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.65 Clinical Trial Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.66 Clinical Trial Patient Recruitment Services Market in India: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.67 Clinical Trial Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.68 Clinical Trial Patient Recruitment Services Market in Latin America, 2022-2035 (USD Billion)
Table 20.69 Clinical Trial Patient Recruitment Services Market in Latin America: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.70 Clinical Trial Patient Recruitment Services Market in Latin America: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.71 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa, 2022-2035 (USD Billion)
Table 20.72 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.73 Clinical Trial Patient Recruitment Services Market in Middle East and North Africa: Distribution by Therapeutic Area, 2022-2035 (USD Billion)
Table 20.74 Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035 (USD Billion)
Table 20.75 Clinical Trial Patient Recruitment Services Market in Rest of the World: Distribution by Trial Phase, 2022-2035 (USD Billion)
Table 20.76 Clinical Trial Patient Recruitment Services Market in Rest of the World, 2022-2035: Distribution by Therapeutic Area, 2022-2035 (USD Billion)

List of Companies

Please reach out to our team for the details.

Source 1: https://www.clinicaltrialsarena.com/marketdata/featureclinical-trial-patient-recruitment/